Literature DB >> 27824289

PEG3 binds to H19-ICR as a transcriptional repressor.

An Ye1, Hongzhi He1, Joomyeong Kim1.   

Abstract

Paternally expressed gene 3 (Peg3) encodes a DNA-binding protein with 12 C2H2 zinc finger motifs. In the current study, we performed ChIP-seq using mouse embryonic fibroblast (MEF) cells. This experiment identified a set of 16 PEG3 genomic targets, the majority of which overlapped with the promoter regions of genes with oocyte expression. These potential downstream genes were upregulated in MEF cells lacking PEG3 protein, suggesting a potential repressor role for PEG3. Our study also identified the imprinting control region (ICR) of H19 as a genomic target. According to the results, PEG3 binds to a specific sequence motif located between the 3rd and 4th CTCF binding sites of the H19-ICR. PEG3 also binds to the active maternal allele of the H19-ICR. The expression levels of H19 were upregulated in MEF cells lacking PEG3, and this upregulation was mainly derived from the maternal allele. This suggests that PEG3 may function as a transcriptional repressor for the maternal allele of H19. Overall, the current study uncovers a potential functional relationship between Peg3 and H19, and also confirms PEG3 as a transcriptional repressor for the identified downstream genes.

Entities:  

Keywords:  CTCF; ChIP-seq; H19; Peg3; imprinting control region; transcriptional factor

Mesh:

Substances:

Year:  2016        PMID: 27824289      PMCID: PMC5193492          DOI: 10.1080/15592294.2016.1255385

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  29 in total

1.  Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro.

Authors:  J Winer; C K Jung; I Shackel; P M Williams
Journal:  Anal Biochem       Date:  1999-05-15       Impact factor: 3.365

2.  CTCF maintains differential methylation at the Igf2/H19 locus.

Authors:  Christopher J Schoenherr; John M Levorse; Shirley M Tilghman
Journal:  Nat Genet       Date:  2002-12-02       Impact factor: 38.330

Review 3.  Imprinted genes and hypothalamic function.

Authors:  Elena Ivanova; Gavin Kelsey
Journal:  J Mol Endocrinol       Date:  2011-09-19       Impact factor: 5.098

Review 4.  Genomic imprinting in mammals.

Authors:  Denise P Barlow; Marisa S Bartolomei
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-02-01       Impact factor: 10.005

5.  Peg3/Pw1 is an imprinted gene involved in the TNF-NFkappaB signal transduction pathway.

Authors:  F Relaix; X J Wei; X Wu; D A Sassoon
Journal:  Nat Genet       Date:  1998-03       Impact factor: 38.330

6.  Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic cancer cell lines.

Authors:  Sean C Dowdy; Bobbie S Gostout; Viji Shridhar; Xiaosheng Wu; David I Smith; Karl C Podratz; Shi-Wen Jiang
Journal:  Gynecol Oncol       Date:  2005-10       Impact factor: 5.482

7.  DNA-binding motif and target genes of the imprinted transcription factor PEG3.

Authors:  Michelle M Thiaville; Jennifer M Huang; Hana Kim; Muhammad B Ekram; Tae-Young Roh; Joomyeong Kim
Journal:  Gene       Date:  2012-10-16       Impact factor: 3.688

8.  H19 acts as a trans regulator of the imprinted gene network controlling growth in mice.

Authors:  Anne Gabory; Marie-Anne Ripoche; Anne Le Digarcher; Françoise Watrin; Ahmed Ziyyat; Thierry Forné; Hélène Jammes; Justin F X Ainscough; M Azim Surani; Laurent Journot; Luisa Dandolo
Journal:  Development       Date:  2009-09-17       Impact factor: 6.868

9.  YY1 is autoregulated through its own DNA-binding sites.

Authors:  Jeong Do Kim; Sungryul Yu; Joomyeong Kim
Journal:  BMC Mol Biol       Date:  2009-08-27       Impact factor: 2.946

10.  Epigenetic instability of imprinted genes in human cancers.

Authors:  Joomyeong Kim; Corey L Bretz; Suman Lee
Journal:  Nucleic Acids Res       Date:  2015-09-03       Impact factor: 16.971

View more
  8 in total

1.  Loss of Snord116 impacts lateral hypothalamus, sleep, and food-related behaviors.

Authors:  Marta Pace; Matteo Falappa; Andrea Freschi; Edoardo Balzani; Chiara Berteotti; Viviana Lo Martire; Fatemeh Kaveh; Eivind Hovig; Giovanna Zoccoli; Roberto Amici; Matteo Cerri; Alfonso Urbanucci; Valter Tucci
Journal:  JCI Insight       Date:  2020-06-18

Review 2.  Long noncoding RNA H19 - a new player in the pathogenesis of liver diseases.

Authors:  Zhihong Yang; Ting Zhang; Sen Han; Praveen Kusumanchi; Nazmul Huda; Yanchao Jiang; Suthat Liangpunsakul
Journal:  Transl Res       Date:  2020-11-20       Impact factor: 10.171

3.  PEG3 control on the mammalian MSL complex.

Authors:  An Ye; Hana Kim; Joomyeong Kim
Journal:  PLoS One       Date:  2017-06-13       Impact factor: 3.240

4.  Allele and dosage specificity of the Peg3 imprinted domain.

Authors:  Corey L Bretz; Wesley D Frey; Ryoichi Teruyama; Joomyeong Kim
Journal:  PLoS One       Date:  2018-05-07       Impact factor: 3.240

5.  MTTL3 upregulates microRNA-1246 to promote occurrence and progression of NSCLC via targeting paternally expressed gene 3.

Authors:  Shaohong Huang; Shaoning Luo; Chulian Gong; Limin Liang; Yi Xiao; Mingan Li; Jinyuan He
Journal:  Mol Ther Nucleic Acids       Date:  2021-02-24       Impact factor: 10.183

Review 6.  Long Noncoding RNA H19: A Novel Therapeutic Target Emerging in Oncology Via Regulating Oncogenic Signaling Pathways.

Authors:  Baokang Wu; Yizhou Zhang; Yang Yu; Chongli Zhong; Qi Lang; Zhiyun Liang; Chao Lv; Feng Xu; Yu Tian
Journal:  Front Cell Dev Biol       Date:  2021-12-16

7.  Oxytocin receptor is regulated by Peg3.

Authors:  Wesley D Frey; Kaustubh Sharma; Terri L Cain; Katsuhiko Nishimori; Ryoichi Teruyama; Joomyeong Kim
Journal:  PLoS One       Date:  2018-08-14       Impact factor: 3.240

8.  Inhibition of LncRNAH19 has the effect of anti-tumour and enhancing sensitivity to Gefitinib and Chemotherapy in Non-small-cell lung cancer in vivo.

Authors:  Yaodong Zhou; Yixin Zhang
Journal:  J Cell Mol Med       Date:  2020-04-13       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.